Blog

During the Spring Festival, China has been facing a difficult time as the coronavirus spread all over the country.  In order to stop the coronavirus, we look forward to the effective prevention and control to stop the outbreak of the virus and the symptomatic treatment.  We also hope the anti-virus vaccines and drugs could beRead more

On December 7, 2019, the 2019 annual meeting of the Biomedical Branch of the Shanghai European and American Alumni Association was held in Shanghai Pudong International Talent Hub.  There were more than 120 biomedical entrepreneurs, investors and scientists from hospitals and scientific institutions to join the meeting.  The annual meeting was organized by the BiomedicineRead more

On Nov. 5th 2019, Shanghai Medicilon Inc. (Medicilon) announced an IPO on Sci-Tech Innovation Board at Shanghai Stock Market, abbreviated as “美迪西”, coded as “688202”. The stock price is ￥41.50 CNY per share and the total amount of shares is 15.5 million, which come up to the total capital of 643 million CNY. The fundRead more

SAPA-NJ Annual Conference will take place in Somerset, NJ on Sept 27-28, 2019.  Sino-American Pharmaceutical Professionals Association (SAPA) , founded in 1993, has grown to be one of the most active and well-recognized Chinese-heritage enduring professional organizations in the United States. SAPA is an independent, nonprofit and professional organization with over 4,000 members in USA, China,Read more

Medicilon successfully exhibit in the ACS Fall 2019 National Meeting which was held in San Diego on August 25-29.  Dr. Xingquan Ma, VP of Chemistry, attended the meeting along with Dr. Walter Xie, VP of US Business Development, Dr. Mingzhu Zhang, VP of US Business Development and Sally Tang, Director of Business Development.  During theRead more

On August 27, 2019, the seminar on Preclinical Research of Innovative Drugs hosted by Shanghai Medicilon Inc. was successfully held in Beijing.  The seminar attracted more than 200 pharmaceutical R&D experts from 150 pharmaceutical companies around Beijing.  The R&D Team of Medicilon shared a lot of relevant knowledge and case study experience of preclinical drugRead more

On August 16-19, 2019, Shanghai Medicilon Inc. successfully organized The 5th Advanced Training Course for Non-clinical Safety Evaluation of Drugs for Study Director, which hosted by Drug Safety Evaluation Research Committee of China Pharmaceutical Association and National Institutes for Food and Drug Control.  The training course lasted for 2 days and 13 experts were invitedRead more

On August 2, 2019, “The Medicilon 15th Anniversary Series Tour Forum – Preclinical Research Seminar” was held at the Pudong International Talent Hub.  There were 150 pharmaceutical R&D experts from nearly 100 pharmaceutical companies to attend the seminar.  The seminar was hosted by Shanghai Medicilon Inc. and co-organized by Pudong International Talent Hub and ShanghaiRead more

Read more

Medicilon held the Preclincial and IND Declaration Seminar in Chengdu, China. Medicilon CEO Chun-Lin Chen gave a speech during the seminar where he shared his experience on IND filling for both US and China. Professor Shuangqing Peng had a topic on New Drug Safety Evaluation Approach. Dr. Baomin Xin, Medicilon VP of DMPK and BA,Read more